Purpose
Therapeutic Drug Monitoring
Method(s)
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS)
Suggested CPT Code(s)
80375
New York State Approval Status

Approved

Turnaround Time

5 days

Test Includes
1 Nateglinide Starlix® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) mcg/mL 100 Oral Hypoglycemic Agent

Specimen Type
Serum or Plasma
Requested Volume
1 mL
Minimum Volume
0.3 mL
Special Handling
Serum: Collect sample in Red top tube
Plasma: Collect sample in Gray top tube (Sodium Fluoride / Potassium Oxalate).
Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines.
Specimen Container
Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
Polymer gel separation tube (SST or PST).

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: 14 day(s)
Refrigerated: 28 day(s)
Frozen (-20 °C): 24 month(s)
Frozen (-70 °C): 6 month(s)
1 Nateglinide Starlix® High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) mcg/mL 100 Oral Hypoglycemic Agent

Interface Map

LOINC® Information